Human papillomavirus infections in women with HIV disease: prevalence, risk, and management.
Among the most common coinfections and comorbidities associated with the immunosuppression induced by HIV are human papillomavirus (HPV) and its associated diseases: external genital warts, low- and high-grade squamous intraepithelial lesions, and genital squamous cell cancers. Studies have consistently shown that HPV infections in HIV-seropositive women are detected more frequently, are more persistent, and are more difficult to treat than are those in HIV-seronegative women. This article reviews the prevalence, risk, and management of HPV associated infections in HIV-seropositive women.
Jay
N
N
Division of Adolescent Medicine, Department of Pediatrics, University of California, San Francisco, USA.
Moscicki
A B
AB
D001005:Anus Neoplasms / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000453:epidemiology* / Q000628:therapy; D006679:HIV Seropositivity / Q000628:therapy; D006801:Humans; D030361:Papillomavirus Infections / Q000453:epidemiology*; D015995:Prevalence; D012307:Risk Factors; D014412:Tumor Virus Infections / Q000453:epidemiology*; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000473:pathology; D014626:Vaginal Smears; D016387:Women's Health; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000473:pathology